VIDEO: Potential field-changing research at Congress on Myeloproliferative Neoplasms
Click Here to Manage Email Alerts
In this video, Brynn H. Parsegov, PA-C, highlighted two presentations from the 14th International Congress on Myeloproliferative Neoplasms.
The first presentation, given by Josef T. Prchal, MD, professor at University of Utah’s division of hematologic malignancies, explored how blood clots and phlebotomy may impact the mechanisms of disease in myeloproliferative neoplasms.
“If this is true, this could really change the field,” Parsegov, physician assistant in the division of hematology and hematologic malignancies at University of Utah’s Huntsman Cancer Institute, said. “I’m really invested in where this goes and helping him to further that research.”
The second presentation, given by Angela G. Fleischman, MD, PhD, associate professor in the division of hematology/oncology at University of California, Irvine, focused on improving patient quality of life.
“I feel like it was just a different take on the disease,” Parsegov said.
She also discussed a big takeaway from the presentation, which focused on how to help patients manage the inflammatory background.
“There’s more that we can do to make our patients feel better,” Parsegov said.
References:
- Fleischman AJ. Studies on the MPN microenvironment. Presented at: 14th International Congress on Myeloproliferative Neoplasms; Oct. 27-28, 2022; Brooklyn, New York.
- Prchal JT. Oxygen-sensing mechanisms and erythrocytosis. Presented at: 14th International Congress on Myeloproliferative Neoplasms; Oct. 27-28, 2022; Brooklyn, New York.
Collapse
Healio Interviews
Click Here to Manage Email Alerts